|
Press Releases
| |
|
Displaying releases:
1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-100
|
| |
Oct-28-2009
|
Palatin Technologies to Present at 8th Annual BIO Investor Forum
|
| |
Sep-29-2009
|
Palatin Technologies to Receive $5 Million from AstraZeneca
|
| |
Sep-15-2009
|
Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at
2009 Heart Failure Society of America Annual Meeting |
| |
Sep-08-2009
|
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009 |
| |
Sep-04-2009
|
Palatin Technologies, Inc. To Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009 |
| |
Sep-03-2009
|
Palatin Technologies to Present at the Rodman & Renshaw
11th Annual Global Investment Conference |
| |
Aug-12-2009
|
Palatin Technologies, Inc. Reports Positive Bremelanotide Study;
Improved Safety Profile with Subcutaneous Administration
|
| |
Aug-12-2009
|
Palatin Technologies, Inc. To Raise $3.1 Million
In Registered Direct Offering
|
| |
Aug-04-2009
|
Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate |
| |
May-15-2009
|
Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 |
| |
Mar-13-2009
|
Palatin Technologies to Present at Cowen Annual Health Care Conference
on March 19, 2009 |
| |
Mar-05-2009
|
Palatin Technologies’ Listing Compliance Plan Accepted by NYSE Alternext US
|
| |
Feb-17-2009
|
Palatin Technologies, Inc. Reports Fiscal Year 2009 Second Quarter Results; Teleconference and Webcast to be held on February 17, 2009 |
| |
Feb-12-2009
|
Palatin Technologies Announces Receipt of $4.1 Million from AstraZeneca
|
| |
Feb-11-2009
|
Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009 |
| |
 |
|
|
